09955.HK
ClouDr Group Limited
HKSE · Healthcare · Medical - Distribution · CN
HKD 0.49
−2.97%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 1.4B | 1.6B | 3.5B | 3.7B | 3.0B |
| Cost of Revenue | 622.0M | 848.1M | 2.6B | 2.8B | 2.2B |
| Gross Profit | 737.8M | 775.1M | 861.7M | 909.4M | 792.1M |
| Operating Expenses | |||||
| R&D Expense | 40.4M | 47.0M | 75.4M | 88.0M | 114.8M |
| SG&A Expense | 843.3M | 1.0B | 1.0B | 1.2B | 1.3B |
| General & Admin Expense | 151.7M | 212.8M | 232.0M | 340.2M | 335.6M |
| Selling & Marketing Expense | 600.2M | 804.9M | 810.5M | 828.8M | 933.2M |
| Other Expenses | 139.1M | 563.7M | 119.9M | (33.4M) | 95.0K |
| Total Operating Expenses | 1.0B | 1.6B | 1.2B | 1.2B | 1.4B |
| Cost and Expenses | 1.6B | 2.5B | 3.9B | 4.0B | 3.6B |
| Operating Income (EBIT) | (285.0M) | (853.3M) | (376.1M) | (314.2M) | (591.6M) |
| Non-Operating | |||||
| Interest Income | — | 2.6M | 905.0K | 2.1M | 3.6M |
| Interest Expense | — | 14.0M | 15.4M | 10.8M | 8.0M |
| Net Interest Income | (8.0M) | (11.4M) | (14.5M) | (8.7M) | (4.4M) |
| Other Non-Op Income/Expense | (75.6M) | (115.6M) | (113.2M) | (13.1M) | (1.1B) |
| Non-Operating Income (excl Interest) | (257.4M) | (273.5M) | 97.7M | 2.3M | 1.1B |
| EBT (Pre-Tax Income) | (360.5M) | (968.9M) | (489.3M) | (327.3M) | (1.7B) |
| Income Tax Expense | 2.0M | (364.0K) | 2.1M | 18.0K | (1.4M) |
| Bottom Line | |||||
| Net Income | (404.8M) | (924.2M) | (516.4M) | (323.1M) | (1.7B) |
| Earnings from Cont. Ops | (362.5M) | (968.5M) | (491.4M) | (327.3M) | (1.7B) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (404.8M) | (924.2M) | (516.4M) | (323.1M) | (1.7B) |
| Per Share | |||||
| Basic EPS | (HK$0.65) | (HK$1.52) | (HK$0.89) | (HK$0.60) | (HK$3.28) |
| Diluted EPS | (HK$0.65) | (HK$1.52) | (HK$0.89) | (HK$0.60) | (HK$3.28) |
| Revenue Per Share | HK$2.28 | HK$2.66 | HK$6.01 | HK$6.82 | HK$5.80 |
| Shares | |||||
| Basic Shares Outstanding | 596.2M | 609.9M | 580.3M | 540.8M | 514.9M |
| Diluted Shares Outstanding | 596.2M | 609.9M | 580.3M | 540.8M | 514.9M |
| Profitability Metrics | |||||
| EBITDA | 36.9M | (495.6M) | (372.3M) | (208.4M) | (1.6B) |
| D&A | 64.4M | 84.1M | 101.5M | 108.2M | 101.9M |
| EBIT | (27.5M) | (579.8M) | (473.9M) | (316.5M) | (1.7B) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026